T1	Pharmacological_substance 33 50	aminoglutethimide
N1000 	Reference T1 MeSH:D000616	aminoglutethimide
T2	Pharmacological_substance 79 92	dexamethasone
N1001 	Reference T2 MeSH:D003907	dexamethasone
T3	Pharmacological_substance 97 109	beta blocker
N1002 	Reference T3 MeSH:D000319	beta blocker
T4	Disorder 158 174	breast carcinoma
N1 	Reference T4 UMLS:C0678222	breast carcinoma
T5	Pharmacological_substance 235 248	dexamethasone
N1003 	Reference T5 MeSH:D003907	dexamethasone
T6	Disorder 320 339	high blood pressure
N2 	Reference T6 UMLS:C0020538	high blood pressure
T7	Pharmacological_substance 367 385	beta-blocker drugs
N1004 	Reference T7 MeSH:D000319	beta-blocker drugs
T8	Pharmacological_substance 450 467	aminoglutethimide
N1005 	Reference T8 MeSH:D000616	aminoglutethimide
T11	Disorder 189 207	metastatic disease
N3 	Reference T11 UMLS:C2939419	metastatic disease
T12	Subject 175 183	patients
T13	Subject 209 228	One of the patients
T14	Subject 291 305	second patient
T17	Subject 387 400	Both patients
T21	Disorder 411 431	severe complications
N4 	Reference T21 UMLS:C0274312	severe complications
N5 	Reference T21 UMLS:C0274312	severe complications
N6 	Reference T21 UMLS:C0274312	severe complications
N7 	Reference T21 UMLS:C0274312	severe complications
T22	Disorder 473 479	cancer
N8 	Reference T22 UMLS:C0006826	cancer
N9 	Reference T22 UMLS:C1306459	cancer
